位置:首页 > 蛋白库 > PNTAA_RHORT
PNTAA_RHORT
ID   PNTAA_RHORT             Reviewed;         384 AA.
AC   Q2RSB2; Q60164;
DT   04-APR-2006, integrated into UniProtKB/Swiss-Prot.
DT   24-JAN-2006, sequence version 1.
DT   03-AUG-2022, entry version 106.
DE   RecName: Full=NAD(P) transhydrogenase subunit alpha part 1;
DE            EC=7.1.1.1 {ECO:0000269|PubMed:12564924, ECO:0000269|PubMed:12791694, ECO:0000269|PubMed:16533815, ECO:0000269|PubMed:17323922};
DE   AltName: Full=Nicotinamide nucleotide transhydrogenase subunit alpha 1;
DE   AltName: Full=Proton-translocating transhydrogenase component 1;
DE   AltName: Full=Pyridine nucleotide transhydrogenase subunit alpha 1;
DE   AltName: Full=dI;
GN   Name=pntAA; Synonyms=nntA1; OrderedLocusNames=Rru_A2183;
OS   Rhodospirillum rubrum (strain ATCC 11170 / ATH 1.1.1 / DSM 467 / LMG 4362 /
OS   NCIMB 8255 / S1).
OC   Bacteria; Proteobacteria; Alphaproteobacteria; Rhodospirillales;
OC   Rhodospirillaceae; Rhodospirillum.
OX   NCBI_TaxID=269796;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8075801; DOI=10.1099/13500872-140-7-1595;
RA   Williams R., Cotton N.P., Thomas C.M., Jackson J.B.;
RT   "Cloning and sequencing of the genes for the proton-translocating
RT   nicotinamide nucleotide transhydrogenase from Rhodospirillum rubrum and the
RT   implications for the domain structure of the enzyme.";
RL   Microbiology 140:1595-1604(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 11170 / ATH 1.1.1 / DSM 467 / LMG 4362 / NCIMB 8255 / S1;
RX   PubMed=21886856; DOI=10.4056/sigs.1804360;
RA   Munk A.C., Copeland A., Lucas S., Lapidus A., Del Rio T.G., Barry K.,
RA   Detter J.C., Hammon N., Israni S., Pitluck S., Brettin T., Bruce D.,
RA   Han C., Tapia R., Gilna P., Schmutz J., Larimer F., Land M., Kyrpides N.C.,
RA   Mavromatis K., Richardson P., Rohde M., Goeker M., Klenk H.P., Zhang Y.,
RA   Roberts G.P., Reslewic S., Schwartz D.C.;
RT   "Complete genome sequence of Rhodospirillum rubrum type strain (S1).";
RL   Stand. Genomic Sci. 4:293-302(2011).
RN   [3]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) IN COMPLEX WITH NAD.
RC   STRAIN=ATCC 11170 / ATH 1.1.1 / DSM 467 / LMG 4362 / NCIMB 8255 / S1;
RX   PubMed=10997900; DOI=10.1016/s0969-2126(00)00171-4;
RA   Buckley P.A., Jackson J.B., Schneider T., White S.A., Rice D.W.,
RA   Baker P.J.;
RT   "Protein-protein recognition, hydride transfer and proton pumping in the
RT   transhydrogenase complex.";
RL   Structure 8:809-815(2000).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) IN COMPLEX WITH NAD AND PNTB,
RP   SUBUNIT, AND REGION.
RC   STRAIN=ATCC 11170 / ATH 1.1.1 / DSM 467 / LMG 4362 / NCIMB 8255 / S1;
RX   PubMed=11250201; DOI=10.1016/s0969-2126(01)00571-8;
RA   Cotton N.P.J., White S.A., Peake S.J., McSweeney S., Baz Jackson J.;
RT   "The crystal structure of an asymmetric complex of the two nucleotide
RT   binding components of proton-translocating transhydrogenase.";
RL   Structure 9:165-176(2001).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (1.81 ANGSTROMS) OF APO ENZYME, AND IN COMPLEX WITH
RP   NADH.
RX   PubMed=12379117; DOI=10.1021/bi020251f;
RA   Prasad G.S., Wahlberg M., Sridhar V., Sundaresan V., Yamaguchi M.,
RA   Hatefi Y., Stout C.D.;
RT   "Crystal structures of transhydrogenase domain I with and without bound
RT   NADH.";
RL   Biochemistry 41:12745-12754(2002).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS) OF MUTANT ASN-132 IN COMPLEX WITH
RP   PNTB, CATALYTIC ACTIVITY, NADH-BINDING KINETICS, SUBSTRATE-NAD(P)
RP   TRANSHYDROGENASE PROTEIN COMPLEX KINETICS, SUBUNIT, AND MUTAGENESIS OF
RP   GLN-132.
RC   STRAIN=ATCC 11170 / ATH 1.1.1 / DSM 467 / LMG 4362 / NCIMB 8255 / S1;
RX   PubMed=12564924; DOI=10.1021/bi027032e;
RA   van Boxel G.I., Quirk P.G., Cotton N.P., White S.A., Jackson J.B.;
RT   "Glutamine 132 in the NAD(H)-binding component of proton-translocating
RT   transhydrogenase tethers the nucleotides before hydride transfer.";
RL   Biochemistry 42:1217-1226(2003).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.61 ANGSTROMS) OF 1-381 IN COMPLEX WITH PNTB AND
RP   THIO-NICOTINAMIDE NUCLEOTIDE ANALOG, CATALYTIC ACTIVITY, AND SUBSTRATE
RP   ANALOG-NAD(P) TRANSHYDROGENASE PROTEIN COMPLEX KINETICS.
RC   STRAIN=ATCC 11170 / ATH 1.1.1 / DSM 467 / LMG 4362 / NCIMB 8255 / S1;
RX   PubMed=12791694; DOI=10.1074/jbc.m303061200;
RA   Singh A., Venning J.D., Quirk P.G., van Boxel G.I., Rodrigues D.J.,
RA   White S.A., Jackson J.B.;
RT   "Interactions between transhydrogenase and thio-nicotinamide Analogues of
RT   NAD(H) and NADP(H) underline the importance of nucleotide conformational
RT   changes in coupling to proton translocation.";
RL   J. Biol. Chem. 278:33208-33216(2003).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (2.20 ANGSTROMS) IN COMPLEXES WITH NAD; NADH;
RP   ADP-RIBOSE AND PNTB.
RC   STRAIN=ATCC 11170 / ATH 1.1.1 / DSM 467 / LMG 4362 / NCIMB 8255 / S1;
RX   PubMed=15323555; DOI=10.1021/bi0497594;
RA   Mather O.C., Singh A., van Boxel G.I., White S.A., Jackson J.B.;
RT   "Active-site conformational changes associated with hydride transfer in
RT   proton-translocating transhydrogenase.";
RL   Biochemistry 43:10952-10964(2004).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (3.10 ANGSTROMS) IN COMPLEX WITH NAD AND PNTB.
RX   PubMed=15670609; DOI=10.1016/j.jmb.2004.11.070;
RA   Sundaresan V., Chartron J., Yamaguchi M., Stout C.D.;
RT   "Conformational diversity in NAD(H) and interacting transhydrogenase
RT   nicotinamide nucleotide binding domains.";
RL   J. Mol. Biol. 346:617-629(2005).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF MUTANTS ALA-127; ASN-135 AND
RP   ALA-138 IN COMPLEXES WITH NAD; NADH AND PNTB, CATALYTIC ACTIVITY,
RP   SUBSTRATE-NAD(P) TRANSHYDROGENASE PROTEIN COMPLEX KINETICS, NADH-BINDING,
RP   AND MUTAGENESIS OF ARG-127; ASP-135 AND SER-138.
RC   STRAIN=ATCC 11170 / ATH 1.1.1 / DSM 467 / LMG 4362 / NCIMB 8255 / S1;
RX   PubMed=16533815; DOI=10.1074/jbc.m513230200;
RA   Brondijk T.H., van Boxel G.I., Mather O.C., Quirk P.G., White S.A.,
RA   Jackson J.B.;
RT   "The role of invariant amino acid residues at the hydride transfer site of
RT   proton-translocating transhydrogenase.";
RL   J. Biol. Chem. 281:13345-13354(2006).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.32 ANGSTROMS) IN COMPLEXES WITH NAD; INACTIVE NADH
RP   ANALOG AND PNTB, CATALYTIC ACTIVITY, AND MOLECULAR DYNAMICS SIMULATIONS AND
RP   TRANSITION STATE MODELING OF NAD(P) TRANSHYDROGENASE PROTEIN COMPLEX.
RC   STRAIN=ATCC 11170 / ATH 1.1.1 / DSM 467 / LMG 4362 / NCIMB 8255 / S1;
RX   PubMed=17323922; DOI=10.1021/bi061843r;
RA   Bhakta T., Whitehead S.J., Snaith J.S., Dafforn T.R., Wilkie J., Rajesh S.,
RA   White S.A., Jackson J.B.;
RT   "Structures of the dI2dIII1 complex of proton-translocating
RT   transhydrogenase with bound, inactive analogues of NADH and NADPH reveal
RT   active site geometries.";
RL   Biochemistry 46:3304-3318(2007).
CC   -!- FUNCTION: The transhydrogenation between NADH and NADP is coupled to
CC       respiration and ATP hydrolysis and functions as a proton pump across
CC       the membrane. {ECO:0000250|UniProtKB:P07001}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+)(in) + NAD(+) + NADPH = H(+)(out) + NADH + NADP(+);
CC         Xref=Rhea:RHEA:47992, ChEBI:CHEBI:15378, ChEBI:CHEBI:57540,
CC         ChEBI:CHEBI:57783, ChEBI:CHEBI:57945, ChEBI:CHEBI:58349; EC=7.1.1.1;
CC         Evidence={ECO:0000269|PubMed:12564924, ECO:0000269|PubMed:12791694,
CC         ECO:0000269|PubMed:16533815, ECO:0000269|PubMed:17323922};
CC   -!- SUBUNIT: Heterotrimer of two alpha chains and a beta (PntB) chain; in
CC       Rhodospirillum, the alpha chain is made of two subunits (PntAA and
CC       PntAB) and forms a dimer. {ECO:0000269|PubMed:10997900,
CC       ECO:0000269|PubMed:11250201, ECO:0000269|PubMed:12564924,
CC       ECO:0000269|PubMed:12791694, ECO:0000269|PubMed:15670609}.
CC   -!- SIMILARITY: Belongs to the AlaDH/PNT family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U05294; AAA62493.1; -; Genomic_DNA.
DR   EMBL; CP000230; ABC22983.1; -; Genomic_DNA.
DR   RefSeq; WP_011390032.1; NC_007643.1.
DR   RefSeq; YP_427270.1; NC_007643.1.
DR   PDB; 1F8G; X-ray; 2.00 A; A/B/C/D=1-384.
DR   PDB; 1HZZ; X-ray; 2.50 A; A/B=1-384.
DR   PDB; 1L7D; X-ray; 1.81 A; A/B/C/D=1-384.
DR   PDB; 1L7E; X-ray; 1.90 A; A/B/C/D=1-384.
DR   PDB; 1NM5; X-ray; 2.40 A; A/B=1-384.
DR   PDB; 1PTJ; X-ray; 2.61 A; A/B=1-381.
DR   PDB; 1U28; X-ray; 2.30 A; A/B=1-384.
DR   PDB; 1U2D; X-ray; 3.00 A; A/B=1-384.
DR   PDB; 1U2G; X-ray; 2.20 A; A/B=1-384.
DR   PDB; 1XLT; X-ray; 3.10 A; A/B/D/E/G/H=1-384.
DR   PDB; 2FR8; X-ray; 2.60 A; A/B=1-384.
DR   PDB; 2FRD; X-ray; 3.20 A; A/B=1-384.
DR   PDB; 2FSV; X-ray; 2.30 A; A/B=1-384.
DR   PDB; 2OO5; X-ray; 2.60 A; A/B=1-384.
DR   PDB; 2OOR; X-ray; 2.32 A; A/B=1-384.
DR   PDBsum; 1F8G; -.
DR   PDBsum; 1HZZ; -.
DR   PDBsum; 1L7D; -.
DR   PDBsum; 1L7E; -.
DR   PDBsum; 1NM5; -.
DR   PDBsum; 1PTJ; -.
DR   PDBsum; 1U28; -.
DR   PDBsum; 1U2D; -.
DR   PDBsum; 1U2G; -.
DR   PDBsum; 1XLT; -.
DR   PDBsum; 2FR8; -.
DR   PDBsum; 2FRD; -.
DR   PDBsum; 2FSV; -.
DR   PDBsum; 2OO5; -.
DR   PDBsum; 2OOR; -.
DR   AlphaFoldDB; Q2RSB2; -.
DR   SMR; Q2RSB2; -.
DR   STRING; 269796.Rru_A2183; -.
DR   EnsemblBacteria; ABC22983; ABC22983; Rru_A2183.
DR   KEGG; rru:Rru_A2183; -.
DR   PATRIC; fig|269796.9.peg.2277; -.
DR   eggNOG; COG3288; Bacteria.
DR   HOGENOM; CLU_003376_2_1_5; -.
DR   OMA; YFPMLMT; -.
DR   OrthoDB; 464096at2; -.
DR   PhylomeDB; Q2RSB2; -.
DR   BRENDA; 7.1.1.1; 5420.
DR   EvolutionaryTrace; Q2RSB2; -.
DR   PRO; PR:Q2RSB2; -.
DR   Proteomes; UP000001929; Chromosome.
DR   GO; GO:0051287; F:NAD binding; IDA:UniProtKB.
DR   GO; GO:0008750; F:NAD(P)+ transhydrogenase (AB-specific) activity; IDA:UniProtKB.
DR   GO; GO:0003957; F:NAD(P)+ transhydrogenase (B-specific) activity; IDA:CACAO.
DR   GO; GO:0070403; F:NAD+ binding; IDA:UniProtKB.
DR   GO; GO:0070404; F:NADH binding; IDA:UniProtKB.
DR   GO; GO:0046983; F:protein dimerization activity; IDA:UniProtKB.
DR   GO; GO:0006740; P:NADPH regeneration; IDA:UniProtKB.
DR   InterPro; IPR008143; Ala_DH/PNT_CS2.
DR   InterPro; IPR008142; AlaDH/PNT_CS1.
DR   InterPro; IPR007886; AlaDH/PNT_N.
DR   InterPro; IPR007698; AlaDH/PNT_NAD(H)-bd.
DR   InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR   Pfam; PF01262; AlaDh_PNT_C; 1.
DR   Pfam; PF05222; AlaDh_PNT_N; 1.
DR   SMART; SM01002; AlaDh_PNT_C; 1.
DR   SMART; SM01003; AlaDh_PNT_N; 1.
DR   SUPFAM; SSF51735; SSF51735; 1.
DR   PROSITE; PS00836; ALADH_PNT_1; 1.
DR   PROSITE; PS00837; ALADH_PNT_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; NAD; NADP; Nucleotide-binding; Reference proteome;
KW   Translocase.
FT   CHAIN           1..384
FT                   /note="NAD(P) transhydrogenase subunit alpha part 1"
FT                   /id="PRO_0000231663"
FT   REGION          126..136
FT                   /note="RQD loop; involved in interaction with PntB"
FT   BINDING         127..129
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000269|PubMed:10997900,
FT                   ECO:0000269|PubMed:11250201, ECO:0000269|PubMed:15670609"
FT   BINDING         132..135
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000269|PubMed:10997900,
FT                   ECO:0000269|PubMed:11250201, ECO:0000269|PubMed:15670609"
FT   BINDING         180..182
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000269|PubMed:10997900,
FT                   ECO:0000269|PubMed:11250201, ECO:0000269|PubMed:15670609"
FT   BINDING         202..204
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000269|PubMed:10997900,
FT                   ECO:0000269|PubMed:11250201, ECO:0000269|PubMed:15670609"
FT   BINDING         234
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000269|PubMed:10997900,
FT                   ECO:0000269|PubMed:11250201, ECO:0000269|PubMed:15670609"
FT   BINDING         247
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000269|PubMed:10997900,
FT                   ECO:0000269|PubMed:11250201, ECO:0000269|PubMed:15670609"
FT   BINDING         266
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000269|PubMed:10997900,
FT                   ECO:0000269|PubMed:11250201, ECO:0000269|PubMed:15670609"
FT   MUTAGEN         127
FT                   /note="R->A,M: No effect on interaction with PntB, but
FT                   hydride transfer inhibited. Much weaker binding to NADH."
FT                   /evidence="ECO:0000269|PubMed:16533815"
FT   MUTAGEN         132
FT                   /note="Q->N: No effect on interaction with PntB, but
FT                   hydride transfer strongly inhibited. No effect on NADH
FT                   binding affinity on its own, but differences in NADH
FT                   binding properties in complex with PntB."
FT                   /evidence="ECO:0000269|PubMed:12564924"
FT   MUTAGEN         135
FT                   /note="D->N: No effect on interaction with PntB, but
FT                   hydride transfer strongly inhibited. No effect on the
FT                   binding affinity to NADH."
FT                   /evidence="ECO:0000269|PubMed:16533815"
FT   MUTAGEN         138
FT                   /note="S->A: No effect on interaction with PntB, but
FT                   hydride transfer strongly inhibited. No effect on the
FT                   binding affinity to NADH."
FT                   /evidence="ECO:0000269|PubMed:16533815"
FT   STRAND          2..5
FT                   /evidence="ECO:0007829|PDB:1L7D"
FT   STRAND          10..12
FT                   /evidence="ECO:0007829|PDB:1PTJ"
FT   HELIX           20..28
FT                   /evidence="ECO:0007829|PDB:1L7D"
FT   STRAND          32..36
FT                   /evidence="ECO:0007829|PDB:1L7D"
FT   TURN            37..40
FT                   /evidence="ECO:0007829|PDB:1L7D"
FT   HELIX           41..43
FT                   /evidence="ECO:0007829|PDB:1L7D"
FT   HELIX           47..52
FT                   /evidence="ECO:0007829|PDB:1L7D"
FT   STRAND          56..60
FT                   /evidence="ECO:0007829|PDB:1L7D"
FT   HELIX           61..65
FT                   /evidence="ECO:0007829|PDB:1L7D"
FT   STRAND          69..75
FT                   /evidence="ECO:0007829|PDB:1L7D"
FT   HELIX           80..82
FT                   /evidence="ECO:0007829|PDB:1L7D"
FT   HELIX           86..89
FT                   /evidence="ECO:0007829|PDB:1L7D"
FT   STRAND          95..99
FT                   /evidence="ECO:0007829|PDB:1L7D"
FT   HELIX           102..104
FT                   /evidence="ECO:0007829|PDB:1L7D"
FT   HELIX           106..114
FT                   /evidence="ECO:0007829|PDB:1L7D"
FT   STRAND          118..121
FT                   /evidence="ECO:0007829|PDB:1L7D"
FT   HELIX           122..124
FT                   /evidence="ECO:0007829|PDB:1L7D"
FT   HELIX           129..134
FT                   /evidence="ECO:0007829|PDB:1L7D"
FT   HELIX           136..155
FT                   /evidence="ECO:0007829|PDB:1L7D"
FT   STRAND          163..165
FT                   /evidence="ECO:0007829|PDB:1L7D"
FT   STRAND          168..170
FT                   /evidence="ECO:0007829|PDB:1L7D"
FT   STRAND          174..178
FT                   /evidence="ECO:0007829|PDB:1L7D"
FT   HELIX           182..193
FT                   /evidence="ECO:0007829|PDB:1L7D"
FT   STRAND          197..201
FT                   /evidence="ECO:0007829|PDB:1L7D"
FT   HELIX           208..213
FT                   /evidence="ECO:0007829|PDB:1L7D"
FT   TURN            223..228
FT                   /evidence="ECO:0007829|PDB:1U2G"
FT   STRAND          233..235
FT                   /evidence="ECO:0007829|PDB:1L7E"
FT   HELIX           247..255
FT                   /evidence="ECO:0007829|PDB:1L7D"
FT   STRAND          259..263
FT                   /evidence="ECO:0007829|PDB:1L7D"
FT   STRAND          268..270
FT                   /evidence="ECO:0007829|PDB:1L7E"
FT   HELIX           278..281
FT                   /evidence="ECO:0007829|PDB:1L7D"
FT   STRAND          289..292
FT                   /evidence="ECO:0007829|PDB:1L7D"
FT   HELIX           295..297
FT                   /evidence="ECO:0007829|PDB:1L7D"
FT   STRAND          309..312
FT                   /evidence="ECO:0007829|PDB:1L7D"
FT   STRAND          315..318
FT                   /evidence="ECO:0007829|PDB:1L7D"
FT   HELIX           323..327
FT                   /evidence="ECO:0007829|PDB:1L7D"
FT   HELIX           328..343
FT                   /evidence="ECO:0007829|PDB:1L7D"
FT   HELIX           344..346
FT                   /evidence="ECO:0007829|PDB:1L7D"
FT   TURN            349..352
FT                   /evidence="ECO:0007829|PDB:1L7D"
FT   STRAND          358..360
FT                   /evidence="ECO:0007829|PDB:1U28"
FT   HELIX           361..366
FT                   /evidence="ECO:0007829|PDB:1L7D"
FT   STRAND          367..370
FT                   /evidence="ECO:0007829|PDB:1L7D"
FT   STRAND          371..374
FT                   /evidence="ECO:0007829|PDB:2OO5"
FT   STRAND          379..381
FT                   /evidence="ECO:0007829|PDB:1L7D"
SQ   SEQUENCE   384 AA;  40277 MW;  B886A640CE2BFA12 CRC64;
     MKIAIPKERR PGEDRVAISP EVVKKLVGLG FEVIVEQGAG VGASITDDAL TAAGATIAST
     AAQALSQADV VWKVQRPMTA EEGTDEVALI KEGAVLMCHL GALTNRPVVE ALTKRKITAY
     AMELMPRISR AQSMDILSSQ SNLAGYRAVI DGAYEFARAF PMMMTAAGTV PPARVLVFGV
     GVAGLQAIAT AKRLGAVVMA TDVRAATKEQ VESLGGKFIT VDDEAMKTAE TAGGYAKEMG
     EEFRKKQAEA VLKELVKTDI AITTALIPGK PAPVLITEEM VTKMKPGSVI IDLAVEAGGN
     CPLSEPGKIV VKHGVKIVGH TNVPSRVAAD ASPLFAKNLL NFLTPHVDKD TKTLVMKLED
     ETVSGTCVTR DGAIVHPALT GQGA
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024